SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-19-013386
Filing Date
2019-04-26
Accepted
2019-04-26 17:01:45
Documents
7
Period of Report
2019-06-10
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A mnov-def14a_20181231.htm DEF 14A 1393165
2 GRAPHIC gtqw5cyd2w14000006.jpg GRAPHIC 1300
3 GRAPHIC gtqw5cyd2w14000003.jpg GRAPHIC 2463
4 GRAPHIC gtqw5cyd2w14000004.jpg GRAPHIC 1177
5 GRAPHIC gtqw5cyd2w14000005.jpg GRAPHIC 26133
6 GRAPHIC gtqw5cyd2w14000002.jpg GRAPHIC 1300
7 GRAPHIC gtqw5cyd2w14000001.jpg GRAPHIC 2463
  Complete submission text file 0001564590-19-013386.txt   1443093
Mailing Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 300 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33185 | Film No.: 19772626
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences